Home British watchdog wants U.S. biotech Alexion to justify cost of drug
 

Keywords :   


British watchdog wants U.S. biotech Alexion to justify cost of drug

2014-03-04 10:59:39| Biotech - Topix.net

Britain's healthcare costs watchdog has asked U.S. biotech group Alexion Pharmaceuticals to explain the high price for its Soliris drug before deciding whether the treatment should be paid for by the state health service.

Tags: cost british drug justify

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
01.11US jobs growth slows as presidential election looms
01.11Heritage Environmental Services Secures Commercial Permit Status for Orange, TX Incinerator
01.11Value for Money tsar linked to string of overspends
01.11Gimme Seaweed Partners with rePurpose Global to Combat Plastic Pollution
01.11Video Catches the Moment a Missouri Battery Recycling Plant Explodes
01.11University of Akron Receives $2M Grant from US DOE for EV Battery Recycling
01.11Iowa Select Farms fights food insecurity year-round
More »